CENTURIA CAPITAL GROUP — Capital/Financing Update 2013

Mar 12, 2013

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement. application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of entity

Centuria Capital Limited

ABN

22 095 454 336

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

⁺Class of ⁺securities issued or to $\mathbf{I}$ be issued

Fully paid ordinary shares

• Number of ⁺securities issued or $\overline{2}$ to be issued (if known) or maximum number which may be issued
• Principal of $\overline{3}$ terms the +securities (e.g. if options, exercise price and expiry date; if partly paid ⁺securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

500,000 fully paid ordinary shares

As per other issued fully paid ordinary shares

⁺ See chapter 19 for defined terms.

$\overline{4}$	Do the + securities rank equally in all respects from the + issue date with an existing + class of quoted +securities?	Yes
	If the additional +securities do not rank equally, please state: the date from which they do the extent to which they participate for the next dividend, (in the case of a distribution) trust, Or interest payment the extent to which they do 0 not rank equally, other than relation to the in next dividend, distribution or interest payment
5	Issue price or consideration	In consideration for entering into an executive employment agreement with Mr Nicholas Collishaw to be appointed as CEO - Listed Property Funds.
6	Purpose of the issue (If issued as consideration for the acquisition of assets, clearly identify those assets)	Issued pursuant to executive an employment agreement referred to in paragraph 5 above.
6a	Is the entity an + eligible entity has obtained that security holder approval under rule 7.1A? If Yes, complete sections 6b - 6h in relation to the + securities the	No
	subject of this Appendix 3B, and comply with section 6i
6b	The date the security holder resolution under rule 7.1A was passed
6с	Number of + securities issued without security holder approval under rule 7.1

$\overline{\phantom{a}}$

⁺ See chapter 19 for defined terms.

• 6d Number of ⁺securities issued with security holder approval under rule 7.1A
• Number of ⁺securities issued 6e with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)
• 6f Number of ⁺securities issued under an exception in rule 7.2
• If ⁺securities issued under rule $6g$ 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the ⁺issue date and both values. Include the source of the VWAP calculation.
• 6h If ⁺securities were issued under rule $7.1A$ for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements
• Calculate the entity's remaining 6i issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements
• ⁺Issue dates 7

Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A.

Cross reference: item 33 of Appendix 3B.

8 Number and ⁺class of all ⁺securities quoted on ASX (including the ⁺securities in section 2 if applicable)

Number	+ Class
78,125,802	Fully paid ordinary shares

11,143,870

12 March 2013

⁺ See chapter 19 for defined terms.

Number and ⁺class of all $\overline{9}$ ⁺securities not quoted on ASX (including the ⁺securities in section 2 if applicable)

Number	+ Class

$10$ trust, distribution policy) on the increased capital (interests)

Dividend policy (in the case of a $\sqrt{\phantom{a}}$ As per existing fully paid ordinary shares

Part 2 - Pro rata issue

11	security holder Is approval N/A required?
12	Is the issue renounceable or non- renounceable?
13	Ratio in which the + securities will be offered
14	+ Class of + securities to which the offer relates
15	+Record date determine to entitlements
16	Will different holdings on registers (or subregisters) be aggregated for calculating entitlements?
17	Policy for deciding entitlements in relation to fractions
18	Names of countries in which the entity has security holders who will not be sent new offer documents Note: Security holders must be told how their entitlements are to be dealt with.
	Cross reference: rule 7.7.
19	Closing date for receipt of acceptances or renunciations

⁺ See chapter 19 for defined terms.

20	Names of any underwriters
21	Amount of any underwriting fee or commission
22	Names of any brokers to the issue
23	Fee or commission payable to the broker to the issue
24	Amount of any handling fee payable to brokers who lodge
	acceptances or renunciations on
	behalf of security holders
25	If the issue is contingent on
	security holders' approval, the
	date of the meeting
26	Date entitlement and acceptance
	form and offer documents will be
	sent to persons entitled
27	If the entity has issued options,
	and the terms entitle option holders participate to on
	exercise, the date on which
	notices will be sent to option
	holders
28	Date rights trading will begin (if applicable)
29	Date rights trading will end (if
	applicable)
30	How do security holders sell
	their entitlements in full through a broker?
31	How do security holders sell part
	of their entitlements through a
	broker and accept for the

balance?

⁺ See chapter 19 for defined terms.

• $32$ How do security holders dispose of their entitlements (except by sale through a broker)?
• ⁺Issue date 33

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

• Type of ⁺securities 34 (tick one) $(a)$ *Securities described in Part 1
• $(b)$

All other ⁺securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

			Tick to indicate you are providing the information or
documents

• If the 'securities are 'equity securities, the names of the 20 largest holders of the 35 additional ⁺securities, and the number and percentage of additional ⁺securities held by those holders
• If the 'securities are 'equity securities, a distribution schedule of the additional 36 *securities setting out the number of holders in the categories $1 - 1,000$ $1,001 - 5,000$ $5,001 - 10,000$ 10,001 - 100,000 100,001 and over

A copy of any trust deed for the additional +securities 37

⁺ See chapter 19 for defined terms.

Entities that have ticked box 34(b)

Number of ⁺securities for which | 38 $n/a$ ⁺quotation is sought ⁺Class of ⁺securities for which 39 quotation is sought Do the ⁺securities rank equally in 40 all respects from the ⁺issue date with an existing ⁺class of quoted ⁺securities? If the additional ⁺securities do not rank equally, please state: • the date from which they do the extent to which they $\bullet$ participate for the next dividend, (in the case of a trust, distribution) or interest payment $\bullet$ the extent to which they do not rank equally, other than in relation to the next dividend. distribution $or$ interest payment Reason for request for quotation 41 now Example: In the case of restricted securities, end of restriction period

(if issued upon conversion of another ⁺security, clearly identify that other 'security)

Number and ⁺class of all $42$ *securities quoted on ASX (including the ⁺securities in clause $38)$

Number	+Class

⁺ See chapter 19 for defined terms.

Quotation agreement

• +Quotation of our additional +securities is in ASX's absolute discretion. ASX $\mathbf{1}$ may quote the ⁺securities on any conditions it decides.
• $\overline{2}$ We warrant the following to ASX.
• The issue of the 'securities to be quoted complies with the law and is $\bullet$ not for an illegal purpose.
• There is no reason why those 'securities should not be granted +quotation.
• An offer of the 'securities for sale within 12 months after their issue will not require disclosure under section $707(3)$ or section $1012C(6)$ of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

• Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any *securities to be quoted and that no-one has any right to return any *securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the *securities be quoted.
• If we are a trust, we warrant that no person has the right to return the $\bullet$ *securities to be quoted under section 1019B of the Corporations Act at the time that we request that the 'securities be quoted.
• We will indemnify ASX to the fullest extent permitted by law in respect of any $\overline{\mathbf{3}}$ claim, action or expense arising from or connected with any breach of the warranties in this agreement.
• We give ASX the information and documents required by this form. If any $\overline{4}$ information or document is not available now, we will give it to ASX before ⁺quotation of the ⁺securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

/∓ == ==

(Director/C Ompany secretary

Date: !. 2. March 2013

Sign here:

Print name:

⁺ See chapter 19 for defined terms.

Appendix 3B - Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

Part 1

Rule 7.1 - Issues exceeding 15% of capital
Step 1: Calculate "A", the base figure from which the placement capacity is calculated
Insert number of fully paid +ordinary securities on issue 12 months before the *issue date or date of agreement to issue	81,262,172
Add the following:
Number of fully paid +ordinary securities $\bullet$ issued in that 12 month period under an exception in rule 7 2	578,946
Number of fully paid + ordinary securities $\bullet$ issued in that 12 month period with shareholder approval
Number of partly paid +ordinary $\bullet$ securities that became fully paid in that 12 month period
Note - Include only ordinary securities here - $\bullet$ other classes of equity securities cannot be added Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed It may be useful to set out issues of $\bullet$ securities on different dates as separate line items
Subtract the number of fully paid +ordinary securities cancelled during that 12 month period	4,215,316
"A"	77,625,802

⁺ See chapter 19 for defined terms.

Step 2: Calculate 15% of "A"
``B"	0.15
	[Note: this value cannot be changed]
Multiply "A" by 0.15	11,643,870
Step 3: Calculate "C", the amount of placement capacity under rule 7.1 that has already been used
Insert number of + equity securities issued or agreed to be issued in that 12 month period not counting those issued: Under an exception in rule 7.2 Under rule 7.1A With security holder approval under rule 7.1 or rule 7.4 Note: This applies to equity securities, unless specifically excluded - not just ordinary securities Include here (if applicable) the securities $\bullet$ the subject of the Appendix 3B to which this form is annexed It may be useful to set out issues of $\bullet$ securities on different dates as separate line items	500,000 [being the equity securities the issue of which is given notice in this Appendix 3B]
"C"	500,000
Step 4: Subtract "C" from ["A" x "B"] to calculate remaining placement capacity under rule 7.1
"A" x 0.15	11,643,870
Note: number must be same as shown in Step 2
Subtract "C"	500,000
Note: number must be same as shown in Step 3
Total ["A" $\times$ 0.15] – "C"	11, 143, 870
	[Note: this is the remaining placement capacity under rule 7.1]

⁺ See chapter 19 for defined terms.

Part 2

Rule 7.1A - Additional placement capacity for eligible entities
Step 1: Calculate "A", the base figure from which the placement capacity is calculated
"A"	N/A
Note: number must be same as shown in Step 1 of Part 1
Step 2: Calculate 10% of "A"
"D"	0.10
	Note: this value cannot be changed
Multiply "A" by 0.10	N/A
Step 3: Calculate "E", the amount of placement capacity under rule 7.1A that has already been used
Insert number of + equity securities issued or agreed to be issued in that 12 month period under rule 7.1A
Notes: This applies to equity securities - not just ordinary securities Include here $-$ if applicable $-$ the securities the subject of the Appendix 3B to which this form is annexed Do not include equity securities issued $\bullet$ under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained It may be useful to set out issues of $\bullet$ securities on different dates as separate line items
``E"	N/A

$\sim$ $\alpha$

⁺ See chapter 19 for defined terms.

Step 4: Subtract "E" from ["A" x "D"] to calculate remaining placement capacity under rule 7.1A
" $A$ " x 0.10	N/A
Note: number must be same as shown in Step 2
Subtract E"
Note: number must be same as shown in Step 3
Total ["A" $\times$ 0.10] – "E"	N/A
	Note: this is the remaining placement capacity under rule 7.1A

⁺ See chapter 19 for defined terms.